drugset / Trial / NCT07122986

A Study to Learn About a Vaccine Against E Coli in Healthy Adults

NCT07122986 ↗

Phase 1 Recruiting 310 enrolled Pfizer
RandomizedParallel-groupDouble-blindBasic science

Summary

This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety and tolerability of E coli vaccines administered intramuscularly to healthy adults.

Timeline

Start
2025-08-11
Primary completion
2028-05-26
Completion
2028-05-26

Drugs

EvaluationDrugModalityDoseRoute
Subject E coli Vaccine 4 Unknown — Intramuscular
Subject E coli Vaccine 5 Unknown — Intramuscular
Subject E coli vaccine 1 Unknown — Intramuscular
Subject E coli vaccine 2 Unknown — Intramuscular
Subject E coli vaccine 3 Unknown — Intramuscular

Indications

No indication recorded.